{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:27:19Z","timestamp":1762507639250},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Tumoral melanosis (TM) is a histologic diagnosis characterized by abundant pigment-laden macrophages in the dermis. It is generally thought to represent a regressed melanoma, although it has also been reported after benign pigmented lesions as well. Determining the antecedent lesion in cases of TM is of clinical importance to accurately guide therapy and prognostication. Comparing the histopathologic and immunohistochemical (IHC) characteristics of TM, halo nevi (HN), and regressing melanoma (RM) may help predict the antecedent lesion in cases of TM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Cases of TM, HN, and RM were selected and assessed for histopathologic (preservation of junctional melanocytic component, depth and width, solar elastosis, fibrosis, and preservation of rete ridge architecture) and IHC (SOX-10, CD138, and PD-1) parameters. PD-L1 immunostaining was also evaluated in cases of HN and RM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Severe solar elastosis, fibrosis, and marked rete ridge effacement were more frequent in RM than in HN. By contrast, numerous plasma cells, clusters of lymphocytes expressing PD-1, and &gt;50% PD-L1 expression in melanocytes were more common in HN than in RM. However, the association of these variables did not reach statistical significance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>Although studies with higher statistical power are needed, this study serves as an initial investigation to characterize the histopathologic and IHC characteristics, which may help better understand TM and its precursor lesions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dad.0000000000001346","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T01:43:16Z","timestamp":1547430196000},"page":"480-487","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of the Inflammatory Infiltrates in Tumoral Melanosis, Regressing Nevi, and Regressing Melanoma"],"prefix":"10.1097","volume":"41","author":[{"given":"Eva Vertes","family":"George","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Florida College of Medicine, Gainesville, FL; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica E.","family":"Kalen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Florida College of Medicine, Gainesville, FL; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti P.","family":"Kapil","sequence":"additional","affiliation":[{"name":"Inform Diagnostics Research Institute, Irving, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Motaparthi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Florida College of Medicine, Gainesville, FL; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230908","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00000372-200208000-00017","article-title":"Melanosis and its meanings","volume":"24","author":"LeBoit","year":"2002","journal-title":"Am J Dermatopathol."},{"key":"R2-20230908","first-page":"e1026","article-title":"Tumoral melanosis associated with pembrolizumab-treated metastatic melanoma","volume":"9","author":"Bari","year":"2017","journal-title":"Cureus"},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjd.14474","article-title":"Extensive tumoral melanosis associated with ipilimumab-treated melanoma","volume":"175","author":"Staser","year":"2016","journal-title":"Br J Dermatol."},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00000372-198712000-00005","article-title":"Plasma cells within the infiltrate of primary cutaneous malignant melanoma of the skin. A confirmation of its histoprognostic value","volume":"9","author":"Mascaro","year":"1987","journal-title":"Am J Dermatopathol."},{"key":"R5-20230908","first-page":"158","article-title":"Plasma cell infiltrate in common acquired melanocytic nevus","volume":"16","author":"Fernandez-Flores","year":"2008","journal-title":"Acta Dermatovenerol Croat."},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1111\/pde.12268","article-title":"Tumoral melanosis in an adolescent after trauma: a clinicopathological dilemma","volume":"31","author":"Dogruk Kacar","year":"2014","journal-title":"Pediatr Dermatol."},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00000372-199804000-00002","article-title":"Nodular melanosis due to epithelial neoplasms: a finding not restricted to regressed melanomas","volume":"20","author":"Flax","year":"1998","journal-title":"Am J Dermatopathol."},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-0560.2006.00609.x","article-title":"Tumoral melanosis involving the sentinel lymph nodes: a case report","volume":"34","author":"Satzger","year":"2007","journal-title":"J Cutan Pathol."},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2133.2006.07370.x","article-title":"Tumoral melanosis as a manifestation of a completely regressed primary melanoma with metastases","volume":"155","author":"Ng","year":"2006","journal-title":"Br J Dermatol."},{"issue":"suppl","key":"R10-20230908","first-page":"35","article-title":"Prediction of lymph node metastases from the histologic features of primary cutaneous malignant melanomas","volume":"6","author":"Weissmann","year":"1984","journal-title":"Am J Dermatopathol."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"107940","DOI":"10.1155\/2013\/107940","article-title":"Immune parameters in the prognosis and therapy monitoring of cutaneous melanoma patients: experience, role, and limitations","volume":"2013","author":"Neagu","year":"2013","journal-title":"Biomed Res Int."},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front Pharmacol."},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.clinthera.2015.02.018","article-title":"The next immune-checkpoint inhibitors: PD-1\/PD-L1 blockade in melanoma","volume":"37","author":"Mahoney","year":"2015","journal-title":"Clin Ther."},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1158\/1078-0432.CCR-16-1821","article-title":"PD-L1 expression in melanoma: a quantitative immunohistochemical antibody comparison","volume":"23","author":"Sunshine","year":"2017","journal-title":"Clin Cancer Res."},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1200\/JCO.2016.67.2477","article-title":"Programmed death-ligand 1 expression and response to the anti-programmed death 1 antibody pembrolizumab in melanoma","volume":"34","author":"Daud","year":"2016","journal-title":"J Clin Oncol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000372-201907000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T05:00:42Z","timestamp":1694149242000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201907000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001346","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}